Lab Med Online.  2020 Oct;10(4):301-306. 10.47429/lmo.2020.10.4.301.

Comparison of Clinical Utility between Phadiatop Assay and AdvanSureTM AlloScreen

• Kim MK
• Kwon MJ
• Park H
• Woo HY

• KMID: 2512269
• DOI: http://doi.org/10.47429/lmo.2020.10.4.301

Abstract

Background
Multiple Allergo-Sorbent Test (MAST) allows simultaneous detection of specific IgE antibodies using multiple allergens, and it is commonly used for allergy screening. Phadiatop assay (Phadia AB, Sweden), including Phadiatop test and Phadiatop Infant test, is a variant of specific IgE test that covers a mixture of common allergens. We compared the clinical utility of Phadiatop assay with that of the MAST AlloScreen (LG Life Science, Korea).
Methods
A total of 218 samples classified by AlloScreen results were collected. Phadiatop test was performed on sera from 61 and 103 aeroallergen-positive and -negative subjects. Phadiatop Infant test was performed on sera from 54 and 103 food and aeroallergen-positive and -negative subjects. When the results of AlloScreen and Phadiatop assay were not identical, we confirmed them using ImmunoCAP (Phadia AB).
Results
The concordance rate between AlloScreen and Phadiatop test was 93.2% (κ=0.86, P<0.001). Eleven (6.7%) of 164 specimens showed discrepant results. The results of AlloScreen did not agree with those of ImmunoCAP. The concordance rate between AlloScreen and Phadiatop Infant test was 97.4% (κ=0.945, P <0.001). Four (2.5%) specimens showed negative results in AlloScreen and positive results in Phadiatop Infant test. Three cases were confirmed as positive and one case was not confirmed through ImmunoCAP.
Conclusions
There was excellent agreement between AlloScreen and Phadiatop assay. Phadiatop assay accurately detected sensitization to common food and aeroallergen mixes. Therefore, Phadiatop assay is recommended as a screening test for allergic diseases.

Keyword

Allergy; Immunoassay; Immunoglobulin E; Hypersensitivity

Reference

1. Silverstein AM. 2000; Clemens freiherr von pirquet: explaining immune complex disease in 1906. Nat Immunol. 1:453–5. DOI: 10.1038/82691. PMID: 11101860.

2. Galli SJ, Tsai M, Piliponsky AM. 2008; The development of allergic inflammation. Nature. 454:445–54. DOI: 10.1038/nature07204. PMID: 18650915. PMCID: PMC3573758.

3. Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, et al. 2014; EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 69:1008–25. DOI: 10.1111/all.12429. PMID: 24909706.

4. Rusznak C, Davies RJ. 1998; ABC of allergies. Diagnosing allergy. BMJ. 316:686–9. DOI: 10.1136/bmj.316.7132.686. PMID: 9522798. PMCID: PMC1112683.

5. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, et al. 2008; Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 100:S1–148. DOI: 10.1016/S1081-1206(10)60305-5. PMID: 18431959.

6. Pastorello EA. 1993; 3. Skin tests for diagnosis of IgE mediated allergy. Allergy. 48:57–62. DOI: 10.1111/j.1398-9995.1993.tb04758.x.

7. Hwang H, Kwon J, Kim JY, Lee HH, Oh CE, Choi GS. 2016; The RIDA allergy screen versus the phadiatop test in 430 consecutive patient specimens. Lab Med. 47:20–9. DOI: 10.1093/labmed/lmv002. PMID: 26732778.

8. Williams P, Sewell WA, Bunn C, Pumphrey R, Read G, Jolles S. 2008; Clinical immunology review series: an approach to the use of the immunology laboratory in the diagnosis of clinical allergy. Clin Exp Immunol. 153:10–8. DOI: 10.1111/j.1365-2249.2008.03695.x. PMID: 18577028. PMCID: PMC2432092.

9. Choi JS, Roh JY, Lee JR. 2014; Clinical availability of component-resolved diagnosis using microarray technology in atopic dermatitis. Ann Dermatol. 26:437–46. DOI: 10.5021/ad.2014.26.4.437. PMID: 25143671. PMCID: PMC4135097.

10. Park KH, Lee J, Lee SC, Son YW, Sim DW, Lee JH, et al. 2017; Comparison of the ImmunoCAP assay and AdvanSure™ AlloScreen advanced multiplex specific IgE detection assay. Yonsei Med J. 58:786–92. DOI: 10.3349/ymj.2017.58.4.786. PMID: 28540992. PMCID: PMC5447110.

11. Park DJ, Lee J, Kim SY, Kwon HJ, Lee HK, Kim Y. 2019; Evaluation of AdvanSure AlloScreen Max panel with 92 different allergens for detecting allergen-specific IgE. Am J Clin Pathol. 151:628–37. DOI: 10.1093/ajcp/aqz023. PMID: 30984971.

12. Park KH, Lee J, Lee SC, Son YW, Sim DW, Lee JH, et al. 2017; Comparison of the ImmunoCAP assay and AdvanSure™ AlloScreen advanced multiplex specific IgE detection assay. Yonsei Med J. 58:786–92. DOI: 10.3349/ymj.2017.58.4.786. PMID: 28540992. PMCID: PMC5447110.

13. Nilsson C, Lilja G, Nordlund M, Berthold M, Borres MP. 2012; Phadiatop Infant^® detects IgE mediated diseases among pre school children: a prospective study. Pediatr Allergy Immunol. 23:159–65. DOI: 10.1111/j.1399-3038.2011.01203.x. PMID: 21929595.

14. Lau S, Nilsson M, Sulser C, Schulz G, Borres MP, Wahn U. 2008; Use of Phadiatop Infant in diagnosis of specific sensitization in young children with wheeze or eczema. Pediatr Allergy Immunol. 19:337–41. DOI: 10.1111/j.1399-3038.2007.00649.x. PMID: 18221462.

15. Goikoetxea MJ, Sanz ML, García BE, Mayorga C, Longo N, Gamboa PM, et al. 2013; Recommendations for the use of in vitro methods to detect specific immunoglobulin E: are they comparable? J Investig Allergol Clin Immunol. 23:448–54. quiz 2 p preceding 455